Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study

Authors: Ulrika Hahn Lundström, Alessandro Gasparini, Rino Bellocco, Abdul Rashid Qureshi, Juan-Jesus Carrero, Marie Evans

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Elderly patients with advanced chronic kidney disease (CKD) have a high risk of death before reaching end-stage kidney disease. In order to allocate resources, such as advanced care nephrology where it is most needed, it is essential to know which patients have the highest absolute risk of advancing to renal replacement therapy (RRT).

Methods

We included all nephrology-referred CKD stage 3b-5 patients in Sweden 2005–2011 included in the Swedish renal registry (SRR-CKD) who had at least two serum creatinine measurements one year apart (+/− 6 months). We followed these patients to either initiation of RRT, death, or September 30, 2013. Decline in estimated glomerular filtration rate (eGFR) (%) was estimated during the one-year baseline period. The patients in the highest tertile of progression (>18.7% decline in eGFR) during the initial year of follow-up were classified as “fast progressors”. We estimated the cumulative incidence of RRT and death before RRT by age, eGFR and progression status using competing risk models.

Results

There were 2119 RRT initiations (24.2%) and 2060 deaths (23.5%) before RRT started. The median progression rate estimated during the initial year was −8.8% (Interquartile range [IQR] - 24.5–6.5%). A fast initial progression rate was associated with a higher risk of RRT initiation (Sub Hazard Ratio [SHR] 2.24 (95% confidence interval [CI] 2.00–2.51) and also a higher risk of death before RRT initiation (SHR 1.27 (95% CI 1.13–1.43). The five year probability of RRT was highest in younger patients (<65 years) with fast initial progression rate (51% in CKD stage 4 and 76% in stage 5), low overall in patients >75 years with a slow progression rate (7, 13, and 25% for CKD stages 3b, 4 and 5 respectively), and slightly higher in elderly patients with a fast initial progression rate (28% in CKD stage 4 and 47% in CKD stage 5) or with diabetic kidney disease.

Conclusions

The 5-year probability of RRT was low among referred slowly progressing CKD patients >75 years of age because of the competing risk of death.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.CrossRefPubMed Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.CrossRefPubMed
2.
go back to reference Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–84.CrossRefPubMed Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–84.CrossRefPubMed
3.
go back to reference De Nicola L, Minutolo R, Chiodini P, et al. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney Int. 2012;82:482–8.CrossRefPubMed De Nicola L, Minutolo R, Chiodini P, et al. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney Int. 2012;82:482–8.CrossRefPubMed
4.
go back to reference Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311:2518–31.CrossRefPubMedPubMedCentral Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311:2518–31.CrossRefPubMedPubMedCentral
5.
go back to reference Anderson S, Halter JB, Hazzard WR, et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol. 2009;20:1199–209.CrossRefPubMed Anderson S, Halter JB, Hazzard WR, et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol. 2009;20:1199–209.CrossRefPubMed
6.
go back to reference Rosansky SJ. Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease. Am J Nephrol. 2012;36:1–10.CrossRefPubMed Rosansky SJ. Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease. Am J Nephrol. 2012;36:1–10.CrossRefPubMed
8.
go back to reference Schön S, Ekberg H, Wikström B, Odén A, Almén J. Renal replacement therapy in Sweden. Scand J Urol Nephrol. 2004;38:332–9.CrossRefPubMed Schön S, Ekberg H, Wikström B, Odén A, Almén J. Renal replacement therapy in Sweden. Scand J Urol Nephrol. 2004;38:332–9.CrossRefPubMed
9.
go back to reference Mårtensson A, Söberg-Broms T, Nordin G. Abstract P017: the analytical quality of measurements of creatinine in plasma in Sweden. Reykjavik, Iceland: Nordic Congress in Clinical Chemistry; 2012. Mårtensson A, Söberg-Broms T, Nordin G. Abstract P017: the analytical quality of measurements of creatinine in plasma in Sweden. Reykjavik, Iceland: Nordic Congress in Clinical Chemistry; 2012.
11.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
12.
go back to reference Lindblad B, Nordin G. External quality assessment of HbA1c and its effect on comparison between Swedish pediatric diabetes clinics. Experiences from the Swedish pediatric diabetes quality register (Swediabkids) and Equalis. Clin Chem Lab Med. 2013;51(10):2045–52. doi:10.1515/cclm-2013-0226.CrossRefPubMed Lindblad B, Nordin G. External quality assessment of HbA1c and its effect on comparison between Swedish pediatric diabetes clinics. Experiences from the Swedish pediatric diabetes quality register (Swediabkids) and Equalis. Clin Chem Lab Med. 2013;51(10):2045–52. doi:10.​1515/​cclm-2013-0226.CrossRefPubMed
13.
go back to reference Buuren S. Flexible imputation of missing data. Boca Raton: CRC Press; 2012.CrossRef Buuren S. Flexible imputation of missing data. Boca Raton: CRC Press; 2012.CrossRef
14.
go back to reference Jason PF, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.CrossRef Jason PF, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.CrossRef
15.
go back to reference Geskus R. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011;67:39–49.CrossRefPubMed Geskus R. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011;67:39–49.CrossRefPubMed
16.
go back to reference Latouche A. A competing risk analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol. 2013;66:648–53.CrossRefPubMed Latouche A. A competing risk analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol. 2013;66:648–53.CrossRefPubMed
17.
go back to reference O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–65. O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–65.
18.
go back to reference De Nicola L, Chiodini P, Zoccali C, et al. Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol. 2011;6:2421–8.CrossRefPubMedPubMedCentral De Nicola L, Chiodini P, Zoccali C, et al. Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol. 2011;6:2421–8.CrossRefPubMedPubMedCentral
19.
go back to reference Hallan SI, Matsushita K, Sang Y, et al. Age and the association of kidney measures with mortality and End-stage renal disease. JAMA. 2012;308:2349–60.CrossRefPubMedPubMedCentral Hallan SI, Matsushita K, Sang Y, et al. Age and the association of kidney measures with mortality and End-stage renal disease. JAMA. 2012;308:2349–60.CrossRefPubMedPubMedCentral
21.
go back to reference Thorsteinsdottir B, Swetz KM, Albright RC. The Ethics of Chronic Dialysis for the Older Patient: Time to Reevaluate the Norms. Clin J Am Soc Nephrol. 2015;10(11):2094–9.CrossRefPubMedPubMedCentral Thorsteinsdottir B, Swetz KM, Albright RC. The Ethics of Chronic Dialysis for the Older Patient: Time to Reevaluate the Norms. Clin J Am Soc Nephrol. 2015;10(11):2094–9.CrossRefPubMedPubMedCentral
22.
go back to reference Stel VS, Dekker FW, Ansell D, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant. 2009;24:3175–82.CrossRefPubMed Stel VS, Dekker FW, Ansell D, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant. 2009;24:3175–82.CrossRefPubMed
23.
go back to reference Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014;6:CD007333. Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014;6:CD007333.
24.
go back to reference Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315:164–74.CrossRefPubMedPubMedCentral Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315:164–74.CrossRefPubMedPubMedCentral
25.
go back to reference Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009;20:2625–30.CrossRefPubMedPubMedCentral Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009;20:2625–30.CrossRefPubMedPubMedCentral
26.
go back to reference Evans M, Tettamanti G, Nyrén O, Bellocco R, Fored CM, Elinder CG. No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med. 2011;269:289–98.CrossRefPubMed Evans M, Tettamanti G, Nyrén O, Bellocco R, Fored CM, Elinder CG. No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med. 2011;269:289–98.CrossRefPubMed
27.
go back to reference O’Hare AM, Batten A, Burrows NR, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59:513–22. O’Hare AM, Batten A, Burrows NR, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59:513–22.
28.
go back to reference Tseng CL, Kern EF, Miller DR, et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med. 2008;168:55–62.CrossRefPubMed Tseng CL, Kern EF, Miller DR, et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med. 2008;168:55–62.CrossRefPubMed
29.
go back to reference Robinson, BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85:158–65.CrossRefPubMed Robinson, BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85:158–65.CrossRefPubMed
30.
go back to reference Qureshi AR, Evans M, Stendahl M, Prütz K-G, Elinder C-G. The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010. Clin Kidney J. 2013;6:352–7.CrossRefPubMedPubMedCentral Qureshi AR, Evans M, Stendahl M, Prütz K-G, Elinder C-G. The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010. Clin Kidney J. 2013;6:352–7.CrossRefPubMedPubMedCentral
31.
go back to reference The Chronic Kidney Disease Prognosis C. Association of estimated glomerular filtration rate and albuminuria with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease cohorts. Kidney Int. 2011;79:1331–40.CrossRef The Chronic Kidney Disease Prognosis C. Association of estimated glomerular filtration rate and albuminuria with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease cohorts. Kidney Int. 2011;79:1331–40.CrossRef
Metadata
Title
Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study
Authors
Ulrika Hahn Lundström
Alessandro Gasparini
Rino Bellocco
Abdul Rashid Qureshi
Juan-Jesus Carrero
Marie Evans
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0473-1

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue